InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by PLATT DAVID, Chairman & CEO. Officer active across 1 companies, notably Bioxytran, INC. In total, 4 reports have been published. The latest transaction was disclosed on 19 November 2021 (Don). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
€388,6623,201,788 shares@ €0.121410.39% mcap54.9% of flow
Common
SEC:0001539497-22-000081·
€388,6623,201,788 shares@ €0.121410.39% mcap27.5% of flow
Common
SEC:0001539497-22-000081:0·
€318,6502,973,988 shares@ €0.107145.1% of flow
Common
SEC:0001539497-21-000793·
€318,6502,973,988 shares@ €0.10718.52% mcap22.5% of flow
Common
SEC:0001539497-21-000793:0·
4 of 4 declarations
About PLATT DAVID
David Platt is CEO of Bioxytran, Inc. He leads the company with a strategic vision, overseeing all operations and ensuring performance objectives are met. His leadership is essential for the development of Bioxytran in the biotechnology sector.
